Medichem SA

General

Total Cases3

Active Cases1

Patents1

CourtsD. New Jersey S.D. New York

TypeOperating Company

Elite Ratings

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
10/16/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	LETTER ORDER Granting Plaintiffs' [285] joint request for an extension of the deadline to file the motions to seal and redactions; the Parties shall file an omnibus motion to seal and their redactions on 10/29/2024. Signed by Judge Karen M. Williams on 10/16/2024. (mag) (Entered: 10/16/2024)
10/16/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	CONSOLIDATION ORDER: The 926 Action and the 8558 Action are consolidated for all purposes, including discovery, case management, and trial, subject to further Order of the Court; all filings in the Consolidated Actions shall use the 926 Action Caption; all filings going forward shall be made in the 926 Action; and the 8558 Action shall be administratively terminated by the Clerk's Office; the Consolidated Actions will follow the amended schedule of the 926 Action. Signed by Judge Karen M. Williams on 10/15/2024. (sms2) (Entered: 10/16/2024) CONSOLIDATION ORDER: The 926 Action and the 8558 Action are consolidated for all purposes, including discovery, case management, and trial, subject to further Order of the Court; all filings in the Consolidated Actions shall use the 926 Action Caption; all filings going forward shall be made in the 926 Action; and the 8558 Action shall be administratively terminated by the Clerk's Office; the Consolidated Actions will follow the amended schedule of the 926 Action. Signed by Judge Karen M. Williams on 10/15/2024. (sms2) (Entered: 10/16/2024)
10/15/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Leave and Extension of Time to File Omnibus Motion to Seal and Redactions re [259] Exhibit (to Document),, [261] Exhibit (to Document),,,, [271] Letter,, [281] Transcript,,, [270] Letter,, [265] Letter,, [260] Exhibit (to Document),, [276] Letter,,, [262] Exhibit (to Document),,. (CALMANN, ARNOLD) (Entered: 10/15/2024) Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Leave and Extension of Time to File Omnibus Motion to Seal and Redactions re [259] Exhibit (to Document),, [261] Exhibit (to Document),,,, [271] Letter,, [281] Transcript,,, [270] Letter,, [265] Letter,, [260] Exhibit (to Document),, [276] Letter,,, [262] Exhibit (to Document),,. (CALMANN, ARNOLD) (Entered: 10/15/2024)
10/15/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	AMENDED SCHEDULING ORDER: Amended Pleadings or motion to join new parties due by 8/26/2025. Pretrial Fact Discovery due by 10/9/2025. Signed by Magistrate Judge Ann Marie Donio on 10/15/2024. (db, ) Modified on 10/16/2024 (tf, ). (Entered: 10/15/2024)
10/14/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Enclosing Proposed Amended Scheduling Order. (Attachments: # [1] Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 10/14/2024)
10/11/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Proposed Consolidation Order (Consolidation with 24-8558-KMW-AMD). (Attachments: # [1] Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 10/11/2024)
10/08/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Transcript of Telephone Conference held on 10/3/2024, before Judge Karen M. Williams. Court Reporter: Sharon Ricci (267-249-8780). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter Agency due, but not filed, by 10/29/2024. Redacted Transcript Deadline set for 11/8/2024. Release of Transcript Restriction set for 1/6/2025. (sms2) (Entered: 10/08/2024) Transcript of Telephone Conference held on 10/3/2024, before Judge Karen M. Williams. Court Reporter: Sharon Ricci (267-249-8780). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter Agency due, but not filed, by 10/29/2024. Redacted Transcript Deadline set for 11/8/2024. Release of Transcript Restriction set for 1/6/2025. (sms2) (Entered: 10/08/2024)
10/04/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Minute Entry for proceedings held before Judge Karen M. Williams: Motion Conference held by telephone on 10/3/2024. Telephone Conference held on the record re [258] MOTION for Summary Judgment of Non-Infringement by EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LIMITED. Ordered [258] Motion TERMINATED, as premature. Order entered. (Court Reporter, Sharon Ricci (267-249-8780)) (mag) (Entered: 10/04/2024) Minute Entry for proceedings held before Judge Karen M. Williams: Motion Conference held by telephone on 10/3/2024. Telephone Conference held on the record re [258] MOTION for Summary Judgment of Non-Infringement by EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LIMITED. Ordered [258] Motion TERMINATED, as premature. Order entered. (Court Reporter, Sharon Ricci (267-249-8780)) (mag) (Entered: 10/04/2024)
10/03/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	TEXT ORDER For the reasons set forth on the record during the October 3, 2024 On the Record Telephone Motion Conference re [258] Motion for Summary Judgment of Non-Infringement by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, it is hereby ORDERED that the Motion for Summary Judgment is TERMINATED as premature, without prejudice to refile upon the completion of discovery. So Ordered by Judge Karen M. Williams on 10/3/24. (nar) (Entered: 10/03/2024) TEXT ORDER For the reasons set forth on the record during the October 3, 2024 On the Record Telephone Motion Conference re [258] Motion for Summary Judgment of Non-Infringement by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, it is hereby ORDERED that the Motion for Summary Judgment is TERMINATED as premature, without prejudice to refile upon the completion of discovery. So Ordered by Judge Karen M. Williams on 10/3/24. (nar) (Entered: 10/03/2024)
10/01/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	TEXT ORDER The Court has scheduled an On the Record Telephone Scheduling Conference for 10/3/2024 at 10:00 AM to address counsel's letters related to the pending Motion for Summary Judgment. The Court will email counsel the dial-in information prior to the conference. So Ordered by Judge Karen M. Williams on 10/1/24. (nar) (Entered: 10/01/2024)